Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Psy Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Psy Therapeutics

Psy Therapeutics

Seed

Psy Therapeutics: Innovating novel medicines for CNS disorders like anxiety, depression, and dementia.

HQ
Boston, MA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Psy Therapeutics was founded with the core mission of discovering and developing novel medicines to improve the lives of people affected by central nervous system (CNS) disorders. The company focuses on conditions such as anxiety, depression, and dementia, aiming to innovate neuropsychiatric care. Psy Therapeutics offers a risk-balanced pipeline of eight compelling drug programs targeting these CNS disorders, positioning itself at the forefront of mental health treatment advancements.

The team at Psy Therapeutics includes leading scientists, clinicians, and business-building executives dedicated to delivering impactful therapies. Notable affiliated individuals include experts in CNS research and development. The company has achieved significant milestones in its drug development pipeline, contributing to the broader field of neuropsychiatric care. Psy Therapeutics' overall impact lies in its potential to transform treatment approaches for CNS disorders, offering hope and improved quality of life for millions affected by these conditions.

Psy Therapeutics - Similar Companies

Psylin Neurosciences logo

Psylin Neurosciences

Sensorium Therapeutics logo

Sensorium Therapeutics

sensorium.bio

Resilience Therapeutics logo

Resilience Therapeutics

Lykos Therapeutics logo

Lykos Therapeutics

lykospbc.com

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

Reset Pharmaceuticals logo

Reset Pharmaceuticals

Pasithea Therapeutics logo

Pasithea Therapeutics

Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

supernus.com

Neurolixis logo

Neurolixis

neurolixis.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

VistaGen Therapeutics logo

VistaGen Therapeutics

Aptinyx logo

Aptinyx

aptinyx.com

Tikvah Therapeutics logo

Tikvah Therapeutics

Euthymics Bioscience logo

Euthymics Bioscience

Axsome Therapeutics logo

Axsome Therapeutics

axsome.com

Psy Therapeutics - Quick Facts

Who are Psy Therapeutics' competitors?

Companies similar to Psy Therapeutics include Psylin Neurosciences, Sensorium Therapeutics, Resilience Therapeutics and Lykos Therapeutics.

When was Psy Therapeutics founded?

Psy Therapeutics was founded in 2012.

Where is Psy Therapeutics' headquarters located?

Psy Therapeutics' headquarters is located in Boston, MA, US.

How much has Psy Therapeutics raised to-date?

As of Apr 5, 2022, Psy Therapeutics has raised a total of $4M (USD).

How many employees does Psy Therapeutics have?

Psy Therapeutics has 30 employees as of Feb 5, 2024.

Psy Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified